Skip to main content

Aminoglycoside Dosage Regimens After Therapeutic Drug Monitoring

Clinical Pharmacokinetics volume 41, pages 791–792 (2002)Cite this article

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 49.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

References

  1. Tod MM, Padoin C, Petitjean O. Individualising aminoglycoside dosage regimens after therapeutic drug monitoring: simple or complex pharmacokinetic methods?. Clin Pharmacokinet 2001; 40(11): 803–14

    Article  PubMed  CAS  Google Scholar 

  2. Begg EJ, Barclay ML, Duffull SB. A suggested approach to once-daily aminoglycoside dosing. Br J Clin Pharmacol 1995; 39: 605–9

    Article  PubMed  CAS  Google Scholar 

  3. Begg EJ, Barclay ML. Aminoglycosides — 50 years on. Br J Clin Pharmacol 1995; 39: 597–603

    Article  PubMed  CAS  Google Scholar 

  4. Finnell DL, Davis GA, Cropp CD, et al. Validation of the Hartford nomogram in trauma surgery patients. Ann Pharmacother 1998; 32(4): 417–21

    Article  PubMed  CAS  Google Scholar 

  5. Kirkpatrick CMJ, Duffull SB, Begg EJ. Once-daily aminoglycoside therapy: potential ototoxicity. Antimicrob Agents Chemother 1997; 41(4): 879–80

    PubMed  CAS  Google Scholar 

  6. Singer C, Smith C, Kreiff D. Once-daily aminoglycoside therapy: potential ototoxicity. Antimicrob Agents Chemother 1996; 40(9): 2209–11

    PubMed  CAS  Google Scholar 

  7. El Bakri F, Pallett A, Smith AG, et al. Ototoxicity induced by once-daily gentamicin. Lancet 1998; 351: 1407–8

    Article  PubMed  CAS  Google Scholar 

  8. Duffull SB, Kirkpatrick CMJ, Begg EJ. Comparison of two Bayesian approaches to dose-individualisation for once-daily aminoglycoside regimens. Br J Clin Pharmacol 1997; 43: 125–35

    Article  PubMed  CAS  Google Scholar 

  9. Kirkpatrick CMJ, Duffull SB, Begg EJ. Pharmacokinetics of gentamicin in 957 patients with varying renal function dosed once daily. Br J Clin Pharmacol 1999; 47: 637–43

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Clinical Pharmacology, Christchurch Hospital, Christchurch, New Zealand

    Carl M. J. Kirkpatrick, Evan J. Begg & Murray L. Barclay

  2. School of Pharmacy, University of Queensland, Brisbane, Australia

    Stephen B. Duffull

Authors
  1. Carl M. J. Kirkpatrick
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Evan J. Begg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Murray L. Barclay
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Stephen B. Duffull
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Kirkpatrick, C.M.J., Begg, E.J., Barclay, M.L. et al. Aminoglycoside Dosage Regimens After Therapeutic Drug Monitoring. Clin Pharmacokinet 41, 791–792 (2002). https://doi.org/10.2165/00003088-200241100-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-200241100-00006

Keywords

  • Minimum Inhibitory Concentration
  • High Peak
  • Aminoglycoside
  • Therapeutic Drug Monitoring
  • Daily Administration